Coronavirus outbreak cripples all major sectors in country; sharp fall in revenues, unemployment to rise in coming days
The coronavirus outbreak happened to be a major setback for hopes of a revival in beleaguered auto sector of the country, which had grappled in the red zone due to sharp fall in demand for over two quarters.
Coronavirus set to hit revenue in pharma, electronic sectors as supply of raw materials from China dwindle
The impact of coronavirus epidemic in China on Indian companies with suppliers and buyers in China will vary across sectors depending on the respective import dependency
Will 2020 be year of pharma sector, Infosys panel gives clean chit on whistle-blower complaint; all this and more on Moneycontrol Pro
The committee determined that there was no evidence of any financial impropriety or executive misconduct.
Reduce GST, form a separate ministry of pharma, zones for creation of medicines, says Indian pharma body to govt
We are seeking from the government stable pricing policy, the Indian Pharmaceutical Alliance said
Firstpost Editor's Picks: Kulbhushan Jadhav case, backlash to Miyah poetry, Kangana Ranaut on spat with media; today's must-read stories
Editor's Picks: ICJ rules in favour of Kulbhushan Jadhav, Neeraj Shekhar's switch to BJP, backlash to Miyah poetry; today's must-read stories.
India's rich list up 34%: Led by Mukesh Ambani, richest 831 collectively own a quarter of country's GDP
Led by Reliance Industries chairman Mukesh Ambani with a networth of Rs 3.71 trillion, there were 831 Indians having a net worth of Rs 1,000 crore or more in 2018, which is 214 individuals more than the 2017 list,
Bangalore is the highest paying city in the country, while pharma and healthcare is the highest paying industry for talent in India, says a report.
The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the price for primary knee replacement of titanium alloy at Rs 38,740 while the price for revision knee replacement of any material was pegged at Rs 62,770.
In India, 71 percent of all healthcare expenses continue to be out of pocket
US FDA’s form 483 to Aurobindo Pharma Hyderabad unit has seven observations relating to violation of good manufacturing practices
Almost 20 percent of global exports in generics from India make it the largest provider of generic medicines globally.
At present, the country exports pharmaceutical goods to 205 countries and every five medicines or tablets consumed in the world are from India
Kumar added that government is aiming to increase the pharma sector growth rate by at least another one or two percent
The government is expected to announce an incentive package, including tax benefits, in the forthcoming Budget for domestic manufacturers.
The recent price cut of 108 drugs by the National Pharmaceutical Pricing Authority (NPPA) is a bold step in expanding people's access to essential medicines after the UPA government slashed prices of 348 drugs in 2012.<br />